S509-0237 Screening compound: 3-(2H-1,3-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-3,9-diazaspiro[5.6]dodecan-10-one

S509-0237 Screening compound: 3-(2H-1,3-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-3,9-diazaspiro[5.6]dodecan-10-one
S509-0237 Screening compound: 3-(2H-1,3-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-3,9-diazaspiro[5.6]dodecan-10-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S509-0237
3-(2H-1,3-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-3,9-diazaspiro[5.6]dodecan-10-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S509-0237

Molecular Formula

C22H28N2O4 (C22 H28 N2 O4)

Compound Name

3-(2H-1,3-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-3,9-diazaspiro[5.6]dodecan-10-one

IUPAC name

3-(2H-13-benzodioxole-5-carbonyl)-9-(cyclopropylmethyl)-39-diazaspiro[5.6]dodecan-10-one

SMILES

O=C(c(cc1)cc2c1OCO2)N(CC1)CCC1(CC1)CCN(CC2CC2)C1=O

InChI

InChI=1S/C22H28N2O4/c25-20-5-6-22(9-12-24(20)14-16-1-2-16)7-10-23(11-8-22)21(26)17-3-4-18-19(13-17)28-15-27-18/h3-4,13,16H,1-2,5-12,14-15H2

InChI Key

IXXHXZMUGDCFKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD30466442

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.015

Distribution Coefficient, logD

2.015

Water Solubility, LogSw

-2.44

Polar Surface Area

51.481

Acid Dissociation Constant (pKa)

23.36

Base Dissociation Constant (pKb)

5.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.64

S509-0237 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S509-0237 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S509-0237?
Check Price and Availability of S509-0237, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S509-0237 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S509-0237
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S509-0237
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S509-0237 available by request